Etesevimab Uses, Dosage, Side Effects, Food Interaction and all others data.

Etesevimab (LY-CoV016, also known as JS016) is a fully human and recombinant monoclonal antibody that targets the SARS-CoV-2 surface spike protein receptor binding domain.

Trade Name Etesevimab
Generic Etesevimab
Etesevimab Other Names Etesevimab
Weight 700mg/20ml
Type Intravenous solution
Groups Investigational
Therapeutic Class
Available Country United States
Last Updated: September 19, 2023 at 7:00 am

How Etesevimab works

Etesevimab aims to neutralize SARS-CoV-2 by specifically binding to the virus' surface spike protein receptor binding domain. This high affinity binding then prevents SARS-CoV-2 from binding to the ACE2 host cell surface receptor. Etesevimab is currently being investigated against COVID-19.

Innovators Monograph

You find simplified version here Etesevimab

*** Taking medicines without doctor's advice can cause long-term problems.